Description
You will support the pharmacovigilance (PV) team in Israel by ensuring safety data and related systems are accurate and compliant.
You will work closely with global and local colleagues, vendors and partners to process safety information, maintain PV records, and support reporting activities.
The role involves:
- Reviewing, extracting and accurately monitoring adverse event (AE) data from spontaneous and solicited sources in safety databases according to procedures.
- Performing quality checks, reconciliations and basic case triage to ensure data completeness and timeliness.
- Maintaining and updating pharmacovigilance agreements, safety documentation and document repositories.
- Running database listings and reports; supporting metric collection and basic trend checks.
- Liaising with local operating companies, vendors and internal teams to gather information and resolve data queries.
- Providing administrative and system support for PV processes, including mailbox triage and document archiving.
Requirements:
- Pharmacist with Israeli license.
- 1–4 years’ experience in pharmacovigilance / drug safety.
- Strong attention to detail and experience with data entry, reconciliation or database work.
- Good IT skills, including Excel and experience with web-based applications or safety databases.
- Ability to communicate clearly in Hebrew and English, both written and verbal.
- Comfortable working in a matrixed team and responding to stakeholders in a timely way.
Preferred Qualifications:
- Experience with ICSR (Individual Case Safety Report) processing.
- Knowledge of local regulatory reporting requirements and pharmacovigilance methodology.
- Prior experience with safety databases (e.g., Argus, Veeva or similar) or document management systems.
- Experience working with vendors or in quality and compliance activities.
- Demonstrated experience in process improvement or KPI analysis.
This role is hybrid, requiring regular on-site work in Israel with flexibility for remote working as agreed with your manager.